A 15ml home care serum with salicylic acid, formulated for acne-prone skin to maintain the results of professional COMEDOPEEL treatments.
LARIMEDICAL COMEDOPEEL Salicylic Acid Serum for Acne Skin 15ml
د.إ 372.00
Description
The LARIMEDICAL COMEDOPEEL Salicylic Acid Serum is a targeted home care serum formulated with salicylic acid for daily use on acne-prone and congested skin. It delivers the proven comedolytic, anti-inflammatory, and pore-clearing benefits of salicylic acid in a concentrated serum format — extending the results of professional COMEDOPEEL treatments between clinic sessions.
✨ What Is It?
A professional-grade home care serum from LARIMEDICAL’s Home Care collection, formulated with salicylic acid specifically for acne-prone skin. Recommended by practitioners as part of the COMEDOPEEL treatment protocol to maintain and extend salon results at home. Available in 15 ml.
💫 Effects
- Unclogs pores and dissolves comedones with daily use
- Reduces active acne breakouts and prevents new lesions
- Controls excess sebum and shine throughout the day
- Refines pore appearance and smoothes skin texture
- Reduces post-acne redness and inflammation
- Extends the results of professional COMEDOPEEL treatments
🌿 Key Ingredients
Salicylic Acid (BHA)
A lipophilic beta-hydroxy acid that penetrates sebum-filled pores to exfoliate from within, dissolve comedones, and reduce acne-causing bacteria. In a daily serum format, it provides ongoing comedolytic maintenance between professional peel sessions.
👤 Suitable For
- Oily, acne-prone, and congested skin
- Daily home care use as part of the LARIMEDICAL COMEDOPEEL treatment protocol
- Skin with blackheads, enlarged pores, and active breakouts
📋 How to Use
- Apply a small amount to cleansed skin on the face, focusing on acne-prone areas.
- Allow to absorb fully before applying moisturizer.
- Use as directed by your aesthetic practitioner — typically evening use.
- Always apply broad-spectrum SPF in the morning when using salicylic acid products.





Reviews
There are no reviews yet.